Search
CNS Pharmaceuticals Inc
CNSPAdd to Watchlist
5.110USD
-0.010-0.20%
Close 09-18 16:00（ET）
7.47MMarket Cap
LossP/E TTM
CNS Pharmaceuticals Inc (CNSP) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to CNS Pharmaceuticals Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
10.000USD+95.31%
CNSP Analyst Recommendation Trends
In the current month, CNSP has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CNSP average Analyst price target in the last month is 10.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
1
1
1
1
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
2
2
2
2
Financial Forecasting
Based on analysts' estimates, CNSP EPS is projected to reach -0.270 in FY2026Q3, following reported EPS of -0.378 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-5.09
-5.37
-0.24
-0.27
-0.27
Actual
-9.70
-7.30
-0.38
--
--
Surprise
-90.62%
-35.97%
-57.69%
--
--
FAQs
What is CNS Pharmaceuticals Inc's price target?
Analysts forecast that CNS Pharmaceuticals Inc's price target is USD 52.00, with the highest forecast at USD 84.00 and the lowest forecast at USD 20.00.
How have CNS Pharmaceuticals IncCNSP's recent earnings per share performed?
The market expectation was USD -0.38, while CNS Pharmaceuticals IncCNSP's earnings per share (EPS) for the previous quarter was USD -7.30. EPS for the next quarter is expected at USD -0.27.
What is the analyst rating for CNS Pharmaceuticals Inc?
Based on the ratings of CNS Pharmaceuticals Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.